Teladoc Health (TDOC)CFO sold ~$97K
Mala Murthy, CFO at Teladoc Health, sold ~$97K of Teladoc Health shares.
- ~$97K
- Approx. value · 13K sh @ $7.59
- 142K
- Holds after · shares reported
- Traded
- Sep 2, 2025
- Filed
- Sep 3, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Sep 2, 2025 · this disclosureInsiderCFO sold ~$97K of TDOC shares in the open market
What came next
- Sep 2, 2025Insider · 4 peopleInsiders: 4 sales (~$129K)
- Sep 3, 2025InsiderOfficer sold ~$31K of TDOC shares in the open market
- Sep 11, 2025InsiderCEO sold ~$127K of TDOC shares in the open market
- Oct 17, 2025Company filing · Form 8-K · Results, Executive changeChanged a top executive or board member, and reported its results (and 1 more item)“On October 17, 2025, Ms. Mala Murthy, Chief Financial Officer of the Company, informed the Company of her decision to resign, effective November 21, 2025, to pursue another career opportunity outside of the healthcare industry.”
- Oct 29, 2025Company filing · Form 8-K · ResultsReported its results
- Dec 9, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On December 9, 2025, Teladoc Health, Inc. (the "Company" or "we") amended its 2023 Employment Inducement Incentive Award Plan (as amended, the “2023 Inducement Plan”) solely to increase the number of shares of common stock, par value $0.001 per share (“Common Stock”), reserved for issuance under the 2023 Inducement Plan by 1,780,000 shares, to a new total of 7,280,000 shares of Common Stock.”
- Dec 11, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On December 11, 2025, Mr. J. Eric Evans notified Teladoc Health, Inc. (the “Company”) of his intention not to stand for reelection at the Company’s 2026 Annual Meeting of Stockholders (the “Annual Meeting”) and to retire from the Board effective as of the conclusion of the Annual Meeting.”
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Teladoc Health
For Teladoc Health, OQRO holds 1 insider filing (SEC Form 4 or Form 144) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its TDOC page.
Other recent filings by Mala Murthy, CHIEF FINANCIAL OFFICER
- SEC Form 4 at Teladoc Health (TDOC)Jun 3, 2025
- SEC Form 4 at Teladoc Health (TDOC)Apr 8, 2025
- SEC Form 4 at Teladoc Health (TDOC)Mar 21, 2025
- SEC Form 4 at Teladoc Health (TDOC)Mar 4, 2025
- SEC Form 4 at Teladoc Health (TDOC)Dec 3, 2024
The full history of Mala Murthy, CHIEF FINANCIAL OFFICER is on the profile page.
How this filing works
Other disclosures at Teladoc Health
- SEC Form 4Oct 6, 2026
- SEC Form 13F-HRMay 15, 2026
- SEC Form 13F-HRFeb 13, 2026
- SEC Form 13F-HRNov 14, 2025
- SEC Form 13F-HRNov 13, 2025
- SEC Form 4Sep 11, 2025
Everything OQRO holds on this company is on its TDOC page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
